0001415889-24-024093.txt : 20240930 0001415889-24-024093.hdr.sgml : 20240930 20240930165323 ACCESSION NUMBER: 0001415889-24-024093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240926 FILED AS OF DATE: 20240930 DATE AS OF CHANGE: 20240930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KENYON LAWRENCE A CENTRAL INDEX KEY: 0001230484 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37759 FILM NUMBER: 241340134 MAIL ADDRESS: STREET 1: C/O OUTLOOK THERAPEUTICS, INC. STREET 2: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 111 S. WOOD AVENUE STREET 2: UNIT #100 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 111 S. WOOD AVENUE STREET 2: UNIT #100 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 4 1 form4-09302024_080919.xml X0508 4 2024-09-26 0001649989 Outlook Therapeutics, Inc. OTLK 0001230484 KENYON LAWRENCE A C/O OUTLOOK THERAPEUTICS, INC. 111 S. WOOD AVENUE, UNIT #100 ISELIN NJ 08830 true true false false Chief Financial Officer 0 Common Stock 2024-09-26 4 P 0 5000 5.6892 A 5946 D Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024. /s/ Lawrence Kenyon 2024-09-30